Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03994380
PHASE1/PHASE2
Use of DNAse in Neutrophilic Asthma
Sponsor: National Jewish Health
View on ClinicalTrials.gov
Summary
In this pilot protocol, the researchers look to determine benefits from use of nebulized rh-DNase for 4 weeks in patients with neutrophilic asthma.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
19
Start Date
2020-02-12
Completion Date
2022-12-31
Last Updated
2026-04-20
Healthy Volunteers
No
Conditions
Interventions
DRUG
RhDNAse Inhalation Solution
rhDNAse 2.5 mg nebulizer daily for 4 weeks
Locations (1)
National Jewish Health
Denver, Colorado, United States